Voters Rejected an Anti-Abortion Measure. State GOP Lawmakers Passed a Similar Bill Anyway.
The new Montana law contains a couple of significant differences from the measure voters rebuffed last fall.
Search
Filter
2,221 - 2,240 of 15,238 Results
-
-
Lost Medicaid Health Coverage? Here’s What You Need to Know
Patient advocates are tackling the “overwhelming task” of connecting people with health insurance as millions lose coverage due to the end of pandemic protections on Medicaid eligibility.
-
Medi-Cal Covers Gender-Transition Treatment, but Getting It Isn’t Easy
Pasha Wrangell has faced delays getting gender-affirming care because of red tape and limited providers. Over more than two years, Wrangell has received only about half the total electrolysis sessions recommended. Wrangell’s insurer through Medi-Cal, California’s Medicaid program, acknowledges the shortage of practitioners.
-
Pioneering Study Links Testicular Cancer Among Military Personnel to ‘Forever Chemicals’
The military first documented health concerns surrounding chemicals known as PFAS decades ago yet has continued to use firefighting foam made with them. Despite scores of lawsuits by its personnel and high rates of testicular cancer among troops, it has been slow to investigate a connection.
By Hannah Norman and Patricia Kime -
As a Union Pushes to Cap Hospital CEO Pay, It’s Accused of Playing Politics
A union is asking Los Angeles city voters to cap hospital executive pay at the U.S. president’s salary. However, hospitals accuse the union of using the proposal as political leverage, and policy experts question whether the policy, if enacted, would be workable.
-
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
-
Amid Lack of Accountability for Bias in Maternity Care, a California Family Seeks Justice
April Valentine’s family wants to know whether racism could have played a role in her death. A KFF Health News analysis shows state regulators are ill-equipped to find discrimination in its many forms.
By Sarah Kwon -
What One Lending Company’s Hospital Contracts Reveal About Financing Patient Debt
Within two years of North Carolina’s public university system going into business with AccessOne to finance patients’ payment plans, nearly half of its patients were in loans that charged interest. As federal scrutiny increases on lenders, KFF Health News is sharing that contract and others obtained through public records requests.
-
How the Texas Trial Changed the Story of Abortion Rights in America
Stark, plaintive testimony from women denied abortion care represents the start of “the 50-year fight to get rid of Dobbs,” one historian says.
By Sarah Varney -
As Many American Cities Get Hotter, Health Systems Face Off Against Heatstroke
With millions of Americans suffering under relentless heat waves this summer, more people are seeking medical attention for heat-related illnesses. As temperatures get more extreme, hospitals, fire departments, and ambulance crews are preparing to treat more patients for heat exhaustion and heatstroke.
-
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
By Darius Tahir -
Journalists Zero In on Opioid Settlement Cash, Congress, and the Medicaid Unwinding
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Survey: Americans Want Weight Loss Drugs Despite High Cost
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
-
As Water Reuse Expands, Proponents Battle the ‘Yuck’ Factor
As drought and climate change threaten water supplies, municipalities around the country are ramping up water reuse efforts. But they have to overcome the “yuk” factor.
By Jim Robbins -
Teens With Addiction Are Often Left to Detox Without Medication
Facilities that offer medically managed substance use treatment for patients under 18 are few and far between in the United States. A Denver hospital is trying to help fill the gap.
Congress Is Out. The Presidential Campaign Is In.
Episode 308Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
-
Look Up Your Hospital: Is It Being Penalized by Medicare?
Each year, Medicare punishes hospitals that have high rates of readmissions and high rates of infections and patient injuries. Check out which hospitals have been penalized.
By Jordan Rau -
Doctors Sound Alarm About Child Nicotine Poisoning as Vapes Flood the US Market
Popular e-cigarettes lack packaging that stops kids from consuming the hazardous nicotine inside.
By Liz Szabo -
‘Conscience’ Bills Let Medical Providers Opt Out of Providing a Wide Range of Care
Opponents of the wave of state legislation say the measures place health providers’ preferences over patients’ rights.
By Carly Graf -
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.
By Arthur Allen